ArticleInternational urology and nephrology2026

Glucagon-like peptide-1 receptor agonists: an emerging hope against nephrolithiasis risk reduction via body weight reduction.

Mehmet Kanbay et al.PubMed ↗Publisher ↗

No numbers read from the abstract.